États-Unis · Plateformes & données · MarketBeat

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $650.00

Publié par MarketBeat · États-Unis il y a 1 h

Wells Fargo & Company lifted their target price on Vertex Pharmaceuticals from $550.00 to $650.00 and gave the company an "overweight" rating in a research note on Tuesday.

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $650.00

À lire aussi

Renew outlines FY2027 adjusted EBITDA guidance of INR 105B to INR 109B as take-private process targets Q1 2027 close

Want to help your adult kids and grandkids? Give them money while you’re still alive.

Where Will QuantumScape Stock Be in 5 Years?

Regal Rexnord Q3 2026 slides: organic growth accelerates to 6.1%

Stock market after midterm elections: What S&P 500 history shows

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $650.00

Partager

À lire aussi

Renew outlines FY2027 adjusted EBITDA guidance of INR 105B to INR 109B as take-private process targets Q1 2027 close

Want to help your adult kids and grandkids? Give them money while you’re still alive.

Where Will QuantumScape Stock Be in 5 Years?

Regal Rexnord Q3 2026 slides: organic growth accelerates to 6.1%

Stock market after midterm elections: What S&P 500 history shows

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030